CMMB · Chemomab Therapeutics Ltd.

$1.39 -0.01 (-0.71%) At close · Jul 24

Market Cap

$9.97M

7.33M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2024-09-12	OrbiMed Israel Partners Limited Partnership	Owner	500,000	$1,015,000	2024-09-12	Morgan Stanley

Showing 1–1 of 1 filings

Key facts CIK 1534248 CUSIP 16385C203 13F (30d) 3 filings 3 filers Visit website Investor relations